Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.3.1.900
Condensed Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jan. 31, 2016
Jan. 31, 2015
Jan. 31, 2016
Jan. 31, 2015
Expenses:        
Research and development $ 4,113,582 $ 2,859,894 $ 7,772,895 $ 5,361,162
General and administrative 2,924,138 1,758,343 6,300,044 3,317,281
Loss from operations (7,037,720) (4,618,237) (14,072,939) (8,678,443)
Net loss before income taxes (7,037,720) (4,618,237) (14,072,939) (8,678,443)
Provision for income taxes     2,172 910
Net loss $ (7,037,720) $ (4,618,237) $ (14,075,111) $ (8,679,353)
Basic net loss per common share (in dollars per share) (1) [1] $ (0.42) $ (0.38) $ (0.89) $ (0.71)
Diluted net loss per common share (in dollars per share) (1) [1] $ (0.42) $ (0.38) $ (0.89) $ (0.71)
Weighted average shares used in computing basic net loss per common share (in shares) (1) [1] 16,761,586 12,312,582 15,794,970 12,272,068
Weighted average shares used in computing diluted net loss per common share (in shares) (1) [1] 16,761,586 12,312,582 15,794,970 12,272,068
[1] See Note 1, “Reverse Stock Split”